GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development CRO announced today that it has entered into a collaboration agreement with U.S. based Endo Pharmaceuticals focused on discovering novel small molecules targeting an exciting protein.
Bioneer has signed an exclusive license agreement with UK technology management company, Plant Bioscience Limited (PBL), regarding use of the Dynamic Gastric Model (DGM) developed at the Institute of Food Research, UK. Bioneer has also acquired PBL's highly successful DGM contract research business, which provides specialist DGM services to the pharmaceutical and food-related industries. The Model Gut services will be integrated into Bioneer's own formulation services offered by Bioneer:FARMA.
Accelrys Inc a leading provider of scientifi c innovation lifecycle management software, is solidifying its market leadership in the laboratory informatics space with the acquisition of its long-time partner Vialis AG, a leading systems integrator based in Liestal, Switzerland serving the pharmaceutical, biotechnology, chemicals, and agro-science industries.
Roche set out to double its capacity for Early Research and Technical Development of therapeutic proteins (TP expand project) at its Biotechnology site in Penzberg, Germany. Avoiding building a new facility, an innovative and well-engineered master plan has been created featuring six independent projects and a GMP IT system known as DAMAS. The DAMAS system is the key component that enables a high level of operational excellence at the Penzberg site.
Hybrigenics, a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris today announces that Hybrigenics Services, its subsidiary specialized in protein interactions, has launched a new service to identify interactions between small molecules and protein targets.
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the introduction of “Uncommon Expertise. Exceptional Results.” as the new corporate tag line to serve as an accompanying message to the corporate logo.
Meet us for business talks in our suite at the Intercontinental
Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of 1.3-micron UHPLC columns to its Kinetex core-shell product line. With the smallest diameter in the Kinetex family, the 1.3-micron is the most efficient particle on the market, delivering measurably better performance than conventional fully porous media on UHPLC equipment.
High Performance Liquid Chromatography (HPLC) has been and continues to be a workhorse of the pharmaceutical laboratory. Throughout the product life cycle from Pre-Formulation to Quality Control, HPLC coupled to Dissolution and Content Uniformity/Assay testing are some of the biggest sample sources for HPLC analysis.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.